Mebendazole & Cancer Research
Evidence-focused overview of mebendazole cancer research, clinical investigation, preclinical findings and safety.
Published September 2, 2026 · Updated September 22, 2026 · By Website Editorial Team
Research interest
Mebendazole is a benzimidazole drug that has been studied experimentally in oncology. This page is designed to separate mechanistic/preclinical research from actual human clinical evidence.
What matters most
For clinical decision-making, human trial design, patient population, endpoints, adverse events and reproducibility matter more than isolated laboratory findings.
Frequently asked questions
Has mebendazole been researched in cancer?
Yes, mebendazole has been investigated in preclinical and some clinical research contexts, but evidence strength varies by cancer type and study.
Does repurposing mean a drug is proven for cancer?
No. A drug's existing approval for another indication does not establish effectiveness for cancer.
Where should patients discuss off-label treatment?
With appropriately licensed clinicians who can consider diagnosis, current therapy, interactions and available evidence.